Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1209

  • Filters activated: Field: Title/Abstract. Clear all
1.

Occurrence of Diabetic Nephropathy After Renal Transplantation Despite Intensive Glycemic Control: An Observational Cohort Study.

Coemans M, Van Loon E, Lerut E, Gillard P, Sprangers B, Senev A, Emonds MP, Van Keer J, Callemeyn J, Daniƫls L, Sichien J, Verbeke G, Kuypers D, Mathieu C, Naesens M.

Diabetes Care. 2019 Feb 14. pii: dc181936. doi: 10.2337/dc18-1936. [Epub ahead of print]

PMID:
30765434
2.

The effect of short-term intensive insulin therapy on circulating T cell subpopulations in patients with newly diagnosed type 2 diabetes mellitus.

Cheng L, Yang F, Cao X, Li GQ, Lu TT, Zhu YQ, Hu Y, Mao XM.

Diabetes Res Clin Pract. 2019 Feb 10;149:107-114. doi: 10.1016/j.diabres.2019.02.007. [Epub ahead of print]

PMID:
30759366
3.

[Should intensive treatment of type 2 diabetes mellitus be an indicator of primary care activity?]

Pacheco J.

Rev Med Chil. 2018 Sep;146(9):1086. doi: 10.4067/s0034-98872018000901086. Spanish. No abstract available.

4.

Early vs late oral nutrition in patients with diabetic ketoacidosis admitted to a medical intensive care unit.

Lipatov K, Kurian KK, Shaver C, White HD, Ghamande S, Arroliga AC, Surani S.

World J Diabetes. 2019 Jan 15;10(1):57-62. doi: 10.4239/wjd.v10.i1.57.

5.

Improved outcome of patients with diabetes mellitus with good glycemic control in the cardiac intensive care unit: a retrospective study.

Sharif K, Ghadir S, Jakubowicz D, Amital H, Bragazzi NL, Watad A, Wainstein J, Bar-Dayan Y.

Cardiovasc Diabetol. 2019 Jan 11;18(1):4. doi: 10.1186/s12933-019-0810-8.

6.

Predictors of long-term glycemic remission after 2-week intensive insulin treatment in newly diagnosed type 2 diabetes.

Wang H, Kuang J, Xu M, Gao Z, Li Q, Liu S, Zhang F, Yu Y, Liang Z, Zhao W, Yang G, Li L, Wang Y, Li G.

J Clin Endocrinol Metab. 2019 Jan 9. doi: 10.1210/jc.2018-01468. [Epub ahead of print]

PMID:
30629195
7.

Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications.

He F, Shu Y, Wang X, Liu X, Liu G, Chen Z, Wang Z, Li L, Liu R, Zhou H, Xu H, Zhang W, Zhou G.

Front Pharmacol. 2018 Dec 11;9:1422. doi: 10.3389/fphar.2018.01422. eCollection 2018.

9.

Fasting Plasma Glucose Indicates Reversibility of the Acute Insulin Response after Short-Term Intensive Insulin Therapy in Patients with Various Duration of Type 2 Diabetes.

Liu L, Yang S, Liu J, Li H, Liu J, Cao X, Xiao H, Li Y.

J Diabetes Res. 2018 Nov 15;2018:9423965. doi: 10.1155/2018/9423965. eCollection 2018.

10.

Intensive versus standard multifactorial cardiovascular risk factor control in screen-detected type 2 diabetes: 5-year and longer-term modelled outcomes of the ADDITION-Leicester study.

Webb D, Dales J, Zaccardi F, Hill S, Moore C, Farooqi A, Griffin S, Davies M, Khunti K.

Diabetes Metab Res Rev. 2018 Dec 6:e3111. doi: 10.1002/dmrr.3111. [Epub ahead of print]

PMID:
30521699
11.

Predicting and understanding the response to short-term intensive insulin therapy in people with early type 2 diabetes.

Nunez Lopez YO, Retnakaran R, Zinman B, Pratley RE, Seyhan AA.

Mol Metab. 2019 Feb;20:63-78. doi: 10.1016/j.molmet.2018.11.003. Epub 2018 Nov 16.

12.

Glucose variability during delirium in diabetic and non-diabetic intensive care unit patients: A prospective cohort study.

van Keulen K, Knol W, Belitser SV, Zaal IJ, van der Linden PD, Heerdink ER, Egberts TCG, Slooter AJC.

PLoS One. 2018 Nov 15;13(11):e0205637. doi: 10.1371/journal.pone.0205637. eCollection 2018.

13.

Alcohol Intake and Weight Loss During Intensive Lifestyle Intervention for Adults with Overweight or Obesity and Diabetes.

Chao AM, Wadden TA, Tronieri JS, Berkowitz RI.

Obesity (Silver Spring). 2019 Jan;27(1):30-40. doi: 10.1002/oby.22316. Epub 2018 Nov 13.

PMID:
30421851
14.

Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.

Imaizumi S, Shiga Y, Ogawa M, Sako H, Nagata Y, Matsunaga A, Shirotani T, Hoshino F, Yahiro E, Uehara Y, Morito N, Tanigawa H, Shimono D, Fukushima M, Sugihara H, Norimatsu K, Kusumoto T, Saku K, Miura SI; ACADEMIE Study Investigators.

Heart Vessels. 2018 Nov 8. doi: 10.1007/s00380-018-1286-2. [Epub ahead of print]

PMID:
30406819
15.

Predictors of Short Intensive Care Unit Stay for Patients with Diabetic Ketoacidosis Using a Novel Emergency Department-Based Resuscitation and Critical Care Unit.

Zhou VL, Shofer FS, Desai NG, Lorincz IS, Mull NK, Adler DH, Greenwood JC.

J Emerg Med. 2019 Feb;56(2):127-134. doi: 10.1016/j.jemermed.2018.09.048. Epub 2018 Nov 3.

PMID:
30401511
16.

Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.

Diabetes Obes Metab. 2018 Nov 4. doi: 10.1111/dom.13575. [Epub ahead of print]

PMID:
30393955
17.

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.

Beddhu S, Chertow GM, Greene T, Whelton PK, Ambrosius WT, Cheung AK, Cutler J, Fine L, Boucher R, Wei G, Zhang C, Kramer H, Bress AP, Kimmel PL, Oparil S, Lewis CE, Rahman M, Cushman WC.

J Am Heart Assoc. 2018 Sep 18;7(18):e009326. doi: 10.1161/JAHA.118.009326.

18.

Cost Calculation for a Flash Glucose Monitoring System for Adults with Type 2 Diabetes Mellitus Using Intensive Insulin - a UK Perspective.

Hellmund R, Weitgasser R, Blissett D.

Eur Endocrinol. 2018 Sep;14(2):86-92. doi: 10.17925/EE.2018.14.2.86. Epub 2018 Sep 10. Review.

19.

The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden.

Bilir SP, Hellmund R, Wehler E, Li H, Munakata J, Lamotte M.

Eur Endocrinol. 2018 Sep;14(2):80-85. doi: 10.17925/EE.2018.14.2.80. Epub 2018 Sep 10. Review.

20.

Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden.

Bilir SP, Hellmund R, Wehler B, Li H, Munakata J, Lamotte M.

Eur Endocrinol. 2018 Sep;14(2):73-79. doi: 10.17925/EE.2018.14.2.73. Epub 2018 Sep 10. Review.

Supplemental Content

Loading ...
Support Center